Loading...
DOCUMENTS
80
NOTICES
153
MOTS CLES
Adalimumab
Immunotherapy
Angiotensin-converting enzyme inhibitors
Alcohol
Adolescent
Etanercept
COVID-19
Care pathway
Burden
Cardiomyopathy
Graft-versus-host disease
Anti-TNF
Azathioprine
Calcium channel blockers
Cardiotoxicity
Auto-Diagnostic
Drug survival
Glucocorticoids
Anticancer drugs
Dermatology
Albinism
Access to care
ASDAS
Ustekinumab
Cancer
Immune-related adverse events
Pharmacoepidemiology
Apre-milast
Adverse side effects
Abus d'antibiotiques
Meta-Analysis
Spondyloarthritis
Ankylosing spondylitis
Atrial fibrillation
Angiotensin receptor blockers
Autoimmune diseases
Antimicrobiens
Ankylosing
Treatment
Anxiété
Placebo
Ethics
Méta-Analyse
Prostate cancer
Auto-immune hepatitis
Alitretinoin
Vigibase®
Amyloidosis
CTLA-4
Autoimmunity
Management
Arrhythmia
Anti-HCV Direct Acting Antivirals DAA
Endocrine toxicity
Cattle
Cardiovascular risk
Anxiety
Biological Therapy
Biologic drug
Sacroiliitis
Antimicrobials
Bacterial rhinosinusitis
Aging
Antimicrobial resistance
Biomarkers
Intensive care
Apremilast
Cardio-oncology
Psoriatic arthritis
Acute Myeloid Leukaemia AML
Primary adrenal insufficiency
CSK tyrosine-protein kinase
Biologic
Infliximab
Arthritis
Immune checkpoint inhibitors
Drug reaction
ArtThese
Quality of life
Biomédicaments
Biologics
Biologic therapy
Sipuleucel-T
Atopic dermatitis
Accelerometer
Pharmacovigilance
Biosimilar Pharmaceuticals
Antibiotics
Stability
Case-Control Studies
Epidemiology
Antibiotic resistance
Cardiovascular therapy
Axial spondyloarthritis
BTK protein
Psoriasis
Biological therapy
Addiction
Beta-lactam antibiotics
Antibiotic misuse
Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379 | |
---|---|
Adresse |
Université Paris-Est Créteil Val de Marne (UPEC) Campus Centre de Créteil |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Émilie SBIDIAN |
Axe(s) de recherche
|
|
COLLABORATIONS
|